Matinas BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

Go back to Matinas BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
(NYSE: MTNB) Delayed: 0.62 -0.01 (1.59%)
Previous Close $0.63    52 Week High $2.01 
Open $0.64    52 Week Low $0.41 
Day High $0.64    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 2,040